Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Upgrades Enhance Dedicated Protein Purification System

By BiotechDaily International staff writers
Posted on 22 May 2013
A flexible and easily customizable protein purification system was designed to enable investigators to automate laborious and repetitive protein purification steps and allow them to concentrate on research applications of the purified sample.

The GE Healthcare (Uppsala, Sweden) ÄKTA Pure Protein Purification System is a flexible and intuitive chromatography platform for fast purification of proteins, peptides, and nucleic acids from microgram to gram levels of target product.

The latest generation of the ÄKTA Pure System boasts a new fraction collector that is covered to minimize contamination and supports flexible combinations of collection vessels from deep-well plates to 250 mL bottles.

In addition, a novel sample pump provides fast, automated, and complete loading of up to seven samples. The pump's integrated air-sensor detects the final drop of sample, automatically preventing the introduction of air while ensuring the complete sample reaches the column. The sample pump also has a robust wash program that removes any air introduced between samples.

The ÄKTA Pure Systems may be customized quickly and easily due to the modular design of both its hardware and software components. The operator is able to choose from more than 20 proven hardware options, and the system may be extended further by interfacing third-party add-ons such as detectors and autosamplers.

Related Links:

GE Healthcare



Channels

Genomics/Proteomics

view channel
Image: Typical antibodies (left) unfold in the harsh environment of the cell. Camelid antibodies (right) are smaller and more stable (Photo courtesy of the Washington University School of Medicine).

Double Targeting Approach Increases Potential for Cancer Treatment with Oncolytic Viruses

Cancer researchers have used a double targeting approach to direct oncolytic viruses specifically to tumor cells where they reproduce until the cancer cells burst, releasing more viruses to infect and... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.